Risk factors for progression of calcific aortic stenosis and potential therapeutic targets

International Journal of Angiology

Volumn 17, Issue 2, 2008, Pages 63-70

  Kamath, Ashvin R ^a   Pai, Ramdas G ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcific aortic stenosis; Progression of aortic stenosis; Prophylaxis; Valvular heart disease

Indexed keywords

EID: 80053040391     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278283     Document Type: Review

References (99)

1. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;2:1220-5. (Pubitemid 23106200)
2. Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation 2004;110:1180-2. (Pubitemid 39202329)
3. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 2006;114:e84-e231. (Pubitemid 44268973)
4. Ross J, Braunwald E. Aortic stenosis. Circulation 1968;38:61-7.
5. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: Relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol 1995;25:305-10.
6. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: Implications for secondary prevention. Circulation 2000;101:2497-502. (Pubitemid 30366254)
7. Pomerance A. Aging changes in human heart valves. Br Heart J 1967;29:222-31.
8. Pomerance A. Pathogenesis of aortic stenosis and its relation to age. Br Heart J 1972;34:569-74.
9. Thubrikar MJ, Aouad J, Nolan SP. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am J Cardiol 1986;58:304-8. (Pubitemid 16052723)
10. Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S, Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol 1993;71:322-7. (Pubitemid 23053442)
11. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-5. (Pubitemid 40279895)
12. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: Literature review and clinical implications. Am Heart J 1996;132:408-17. (Pubitemid 26292409)
13. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26. (Pubitemid 40875006)
14. Liebe V, Brueckmann M, Borggrefe M, Kaden JJ. Statin therapy of calcific aortic stenosis: Hype or hope? Eur Heart J 2006;27:773-8.
15. Novaro GM, Griffin BP. Calcific aortic stenosis: Another face of atherosclerosis? Cleve Clin J Med 2003;70:471-7. (Pubitemid 36621500)
16. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-22. (Pubitemid 29227640)
17. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-30. (Pubitemid 35222217)
18. Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 2004;44:1859-66. (Pubitemid 39424087)
19. Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-7. (Pubitemid 40381303)
20. Kaden JJ, Dempfle CE, Grobholz R, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003;170:205-11. (Pubitemid 37377791)
21. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. Atorvastatin inhibits hypercholesteremia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 2005;112:1229-34.
22. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-20. (Pubitemid 40629039)
23. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4. (Pubitemid 36547209)
24. Rajamannan NM. Calcific aortic stenosis: A disease ready for prime time. Circulation 2006;114:2007-9. (Pubitemid 44711847)
25. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2163-8.
26. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997;17:547-52. (Pubitemid 27133146)
27. Strickberger SA, Schulman SP, Hutchins GM. Association of Paget's disease of bone with calcific aortic valve disease. Am J Med 1987;82:953-6.
28. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-8. (Pubitemid 32973456)
29. Ortlepp JR, Schmitz F, Mevissen V, et al. The amount of calciumdeficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004;25:514-22. (Pubitemid 38524277)
30. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987;59:998-9. (Pubitemid 17074253)
31. Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkilä J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994;15:865-70. (Pubitemid 24223943)
32. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4. (Pubitemid 27116107)
33. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:4724.
34. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. Development and progression of aortic valve stenosis: Atherosclerosis risk factors - a causal relationship? A clinical morphologic study. Clin Cardiol 1991;14:995-9.
35. Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984;37:407-15. (Pubitemid 14134891)
36. Mautner GC, Mautner SL, Cannon RO III, Hunsberger SA, Roberts WC. Clinical factors useful in predicting aortic valve structure in patients > 40 years of age with isolated valvular aortic stenosis. Am J Cardiol 1993;72:194-8. (Pubitemid 23205877)
37. Gotoh T, Kuroda T, Yamasawa M, et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995;76:928-32.
38. Wilmshurst PT, Stevenson RN, Griffiths H, Lord JR. A casecontrol investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis. Heart 1997;78:475-9. (Pubitemid 27515108)
39. Novaro GM, Pearce GL, Sprecher DL, Griffin BP. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis 2001;10:19-24. (Pubitemid 32104459)
40. Chui MC, Newby DE, Panarelli M, Bloomfield P, Boon NA. Association between calcific aortic stenosis and hypercholesterolemia: Is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin Cardiol 2001;24:52-5. (Pubitemid 32044545)
41. Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart 1998;80:583-90. (Pubitemid 28561693)
42. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients. Am J Cardiol 1984;54:20-30. (Pubitemid 14085344)
43. Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D. Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest 1993;103:1715-9. (Pubitemid 23174303)
44. Nassimiha D, Aronow WS, Ahn C, Goldman ME. Rate of progression of valvular aortic stenosis in patients > or = 60 years of age. Am J Cardiol 2001;87:807-9. (Pubitemid 32209108)
45. Yap SC, Kouwenhoven GC, Takkenberg JJ, et al. Congenital aortic stenosis in adults: Rate of progression and predictors of clinical outcome. Int J Cardiol 2007;122:224-31. (Pubitemid 47615186)
46. Kume T, Kawamoto T, Okura H, et al. Rapid progression of mild to moderate aortic stenosis in patients older than 80 years. J Am Soc Echocardiogr 2007;20:1243-6. (Pubitemid 350027812)
47. Urena P, Malergue MC, Goldfarb B, Prieur P, Guedon-Rapoud C, Petrover M. Evolutive aortic stenosis in hemodialysis patients: Analysis of risk factors. Nephrologie 1999;20:217-25. (Pubitemid 29398188)
48. Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol 1999;84:1044-8. (Pubitemid 29505373)
49. Novaro GM, Katz R, Aviles RJ, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: The Cardiovascular Health Study. J Am Coll Cardiol 2007;50:1992-8. (Pubitemid 350046337)
50. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693-5. (Pubitemid 32831111)
51. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-70. (Pubitemid 27191003)
52. Roger VL, Tajik AJ, Bailey KR, Oh JK, Taylor CL, Seward JB. Progression of aortic stenosis in adults: New appraisal using Doppler echocardiography. Am Heart J 1990;119:331-8. (Pubitemid 20064498)
53. Pate GE. Association between aortic stenosis and hypertension. J Heart Valve Dis 2002;11:612-4.
54. Cuniberti LA, Stutzbach PG, Guevara E, Yannarelli GG, Laguens RP, Favaloro RR. Development of mild aortic valve stenosis in a rabbit model of hypertension. J Am Coll Cardiol 2006;47:2303-9. (Pubitemid 43795060)
55. Ngo MV, Gottdiener JS, Fletcher RD, Fernicola DJ, Gersh BJ. Smoking and obesity are associated with the progression of aortic stenosis. A J Geriatr Cardiol 2001;10:86-90. (Pubitemid 32215684)
56. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcomes in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7. (Pubitemid 30659472)
57. Yilmaz MB, Guray U, Guray Y, et al. Lipid profile of patients with aortic stenosis might be predictive of rate of progression. Am Heart J 2004;147:915-8. (Pubitemid 38881008)
58. Wongpraparut N, Apiyasawat S, Crespo G, Yazdani K, Jacobs LE, Kotler MN. Determinants of progression of aortic stenosis in patients aged > or = 40 years. Am J Cardiol 2002;89:350-2. (Pubitemid 34113802)
59. Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Pract 2003;94:40-5.
60. Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circulation 2005;69:1535-9. (Pubitemid 41743971)
61. Kume T, Kawamoto T, Akasaka T, et al. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J Am Soc Echocardiogr 2006;19:914-8. (Pubitemid 43974906)
62. Fujise K, Amerling R, Sherman W. Rapid progression of mitral and aortic stenosis in a patient with secondary hyperparathyroidism. Br Heart J 1993;70:282-4. (Pubitemid 23276244)
63. Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002;162:2345-7. (Pubitemid 35332517)
64. Nassimiha D, Aronow WS, Ahn C, Goldman ME. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol 2001;87:1313-4. (Pubitemid 32493881)
65. Pohle K, Mäffert R, Ropers D, et al. Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001;104:1927-32. (Pubitemid 32983236)
66. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:185-7.
67. Lester SJ, McElhinney DB, Miller JP, Lutz JT, Otto CM, Redberg RF. Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis. Circulation 2000;101:1947-52. (Pubitemid 30225276)
68. Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: A surgical pathologic study of 646 cases. Mayo Clin Proc 1987;62:119-23. (Pubitemid 17016453)
69. Fernandes SM, Khairy P, Sanders SP, Colan SD. Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol 2007;49:2211-4. (Pubitemid 46824114)
70. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-82. (Pubitemid 32912714)
71. Gerber IL, Stewart RA, Hammett CJ, et al. Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 2003;92:1129-32. (Pubitemid 37329546)
72. Sánchez PL, Santos JL, Kaski JC, et al; Grupo AORTICA (Grupo de Estudio de la Estenosis Aórtica). Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-3. (Pubitemid 41828129)
73. Sánchez PL, Mazzone AM. C-reactive protein in aortic valve disease. Cardiovasc Ultrasound 2006;4:24-7.
74. Jeevanantham V, Singh N, Izuora K, D'Souza JP, Hsi DH. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease. Mayo Clin Proc 2007;82:171-4. (Pubitemid 46198475)
75. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: From the bench to the bedside-emerging clinical and cellular concepts. Heart 2003;89:801-5. (Pubitemid 36760652)
76. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher D, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-9. (Pubitemid 33043301)
77. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensinconverting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-5. (Pubitemid 39202347)
78. Cowell SJ, Newby DE, Prescott RJ, et al; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97.
79. Rosenhek R. Statins for aortic stenosis. N Engl J Med 2005;352:2441-3. (Pubitemid 40958444)
80. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-61. (Pubitemid 46177435)
81. Rosseboø AB, Pedersen TR, Allen C, et al. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol 2007;99:970-3. (Pubitemid 46483289)
82. O'Brien KD, Zhao XQ, Shavelle DM, et al. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med 2004;52:185-91. (Pubitemid 38856421)
83. Routledge HC, Townend JN. ACE inhibition in aortic stenosis: Dangerous medicine or golden opportunity? J Hum Hypertens 2001;15:659-67. (Pubitemid 32975863)
84. Newby DE, Cowell SJ, Boon NA. Emerging medical treatments for aortic stenosis: Statins, angiotensin converting enzyme inhibitors, or both? Heart 2006;92:729-34. (Pubitemid 43799199)
85. O'Brien KD, Probstfield JL, Caulfield MT, et al. Angiotensinconverting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005;165:858-62. (Pubitemid 40563231)
86. Jimenez-Candil J, Bermejo J, Yotti R, et al. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: A drug withdrawal study. Heart 2005;91:1311-8. (Pubitemid 41360950)
87. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 2007;115;2533-9. (Pubitemid 46763227)
88. Kaden JJ, Reinöhl JO, Blesch B, et al. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int J Mol Med 2007;20:193-7.
89. Mills WR, Einstadter D, Finkelhor RS. Relation of calciumphosphorus product to the severity of aortic stenosis in patients with normal renal function. Am J Cardiol 2004;94:1196-8. (Pubitemid 39424231)
90. Arishiro K, Hoshiga M, Negoro N, et al. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J Am Coll Cardiol 2007;49:1482-9. (Pubitemid 46482919)
91. Drolet M, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003;41:1211-7. (Pubitemid 36384911)
92. Malergue MC, Urena P, Prieur P, Guedon-Rapoud C, Petrover M. Incidence and development of aortic stenosis in chronic hemodialysis. An ultrasonographic and biological study of 112 patients. Arch Mal Coeur Vaiss 1997;90:1595-601. (Pubitemid 127512493)
93. Chaliki HP, Brown ML, Sundt TM, Tajik AJ. Timing of operation in asymptomatic severe aortic stenosis. Expert Rev Cardiovasc Ther 2007;5:1065-71. (Pubitemid 350303041)
94. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: Benefit of aortic valve replacement. Ann Thorac Surg 2006;82:2116-22.
95. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997;337:32-41. (Pubitemid 27290846)
96. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of "degenerative" valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-53. (Pubitemid 24242754)
97. Caira FC, Stock SR, Gleason TG, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 2006;47:1707-12.
98. Pai RG. Degenerative valve disease. J Am Coll Cardiol 2006;48:2601. (Pubitemid 44881234)
99. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5. (Pubitemid 40875002)